Stroke and Vascular Neurology

Article	Citations
Acute cerebrovascular disease following COVID-19: a single center, retrospective, observational study	492
China Stroke Statistics 2019: A Report From the National Center for Healthcare Quality Management in Neurological Diseases, China National Clinical Research Center for Neurological Diseases, the Chine	300
Chinese Stroke Association guidelines for clinical management of cerebrovascular disorders: executive summary and 2019 update of clinical management of ischaemic cerebrovascular diseases	141
Consensus for prevention and management of coronavirus disease 2019 (COVID-19) for neurologists	98
China Stroke Statistics: an update on the 2019 report from the National Center for Healthcare Quality Management in Neurological Diseases, China National Clinical Research Center for Neurological Dise	92
Decline in stroke alerts and hospitalisations during the COVID-19 pandemic	65
Prognostic value of systemic immune–inflammation index in acute/subacute patients with cerebral venous sinus thrombosis	45
Chinese Stroke Association guidelines for clinical management of cerebrovascular disorders: executive summary and 2019 update of clinical management of stroke rehabilitation	42
Clinical time course of COVID-19, its neurological manifestation and some thoughts on its management	41
Cerebral microhaemorrhage in COVID-19: a critical illness related phenomenon?	39
Safety and efficacy of tenecteplase versus alteplase in patients with acute ischaemic stroke (TRACE): a multicentre, randomised, open label, blinded-endpoint (PROBE) controlled phase II study	36
Therapeutic application of exosomes in ischaemic stroke	32
Intracerebral haemorrhage: from clinical settings to animal models	31
Clopidogrel with aspirin in High-risk patients with Acute Non-disabling Cerebrovascular Events II (CHANCE-2): rationale and design of a multicentre randomised trial	31
Advances in endovascular aneurysm management: coiling and adjunctive devices	30
Novel role of STAT3 in microglia-dependent neuroinflammation after experimental subarachnoid haemorrhage	30
PolyvasculaR Evaluation for Cognitive Impairment and vaScular Events (PRECISE)—a population-based prospective cohort study: rationale, design and baseline participant characteristics	29
Decline in subarachnoid haemorrhage volumes associated with the first wave of the COVID-19 pandemic	29
Chinese Stroke Association guidelines for clinical management of cerebrovascular disorders: executive summary and 2019 update of clinical management of intracerebral haemorrhage	29
Incidence and prevalence of moyamoya disease in urban China: a nationwide retrospective cohort study	27
Chinese Stroke Association guidelines for clinical management of cerebrovascular disorders: executive summary and 2019 update of clinical management of cerebral venous sinus thrombosis	25
Chinese Stroke Association guidelines for clinical management of cerebrovascular disorders: executive summary and 2019 update on organizational stroke management	23
Inflammatory biomarkers and cerebral small vessel disease: a community-based cohort study	23
Transradial versus transfemoral access for anterior circulation mechanical thrombectomy: analysis of 375 consecutive cases	21
Cerebral venous sinus thrombosis after ChAdOx1 nCov-19 vaccination with a misleading first cerebral MRI scan	20

Low serum albumin levels predict poor outcome in patients with acute ischaemic stroke or transient ischaemic attack	20
Effects of vitamin E on stroke: a systematic review with meta-analysis and trial sequential analysis	19
Tranexamic acid for acute intracerebral haemorrhage growth based on imaging assessment (TRAIGE): a multicentre, randomised, placebo-controlled trial	18
Successful management of vaccine-induced immune thrombotic thrombocytopenia-related cerebral sinus venous thrombosis after ChAdOx1 nCov-19 vaccination	18
Impact of aspiration catheter size on first-pass effect in the combined use of contact aspiration and stent retriever technique	18
Associations of HDL-C/LDL-C with myocardial infarction, all-cause mortality, haemorrhagic stroke and ischaemic stroke: a longitudinal study based on 384 093 participants from the UK Biobank	17
Strategy for reliable identification of ischaemic stroke, thrombolytics and thrombectomy in large administrative databases	17
Worldwide 1-month case fatality of ischaemic stroke and the temporal trend	16
Changing the strategy and culture of stroke awareness education in China: implementing Stroke 1-2-0	16
Chinese Stroke Association guidelines for clinical management of cerebrovascular disorders: executive summary and 2019 update of the management of high-risk population	16
Cerebral small vessel disease or intracranial large vessel atherosclerosis may carry different risk for future strokes	16
Inconsistent centralised versus non-centralised ischaemic stroke aetiology	16
Different aspects of cognitive function in adult patients with moyamoya disease and its clinical subtypes	16
Endovascular thrombectomy with or without intravenous alteplase for acute ischemic stroke due to large vessel occlusion: a systematic review and meta-analysis of randomized trials	16
Characterising acute ischaemic stroke thrombi: insights from histology, imaging and emerging impedance-based technologies	15
Multimodal management of giant cerebral aneurysms: review of literature and case presentation	15
Haemodynamic analysis of adult patients with moyamoya disease: CT perfusion and DSA gradings	15
Association of elevated hs-CRP and multiple infarctions with outcomes of minor stroke or TIA: subgroup analysis of CHANCE randomised clinical trial	15
Metabolic syndrome, intracranial arterial stenosis and cerebral small vessel disease in community-dwelling populations	15
Role of depressive symptoms in cardiometabolic diseases and subsequent transitions to all-cause mortality: an application of multistate models in a prospective cohort study	15
Effectiveness of intravenous r-tPA versus UK for acute ischaemic stroke: a nationwide prospective Chinese registry study	15
Mechanisms of fibrinolysis resistance and potential targets for thrombolysis in acute ischaemic stroke: lessons from retrieved stroke emboli	14
Plasma from healthy donors protects blood–brain barrier integrity via FGF21 and improves the recovery in a mouse model of cerebral ischaemia	14
Gastrointestinal bleeding during acute ischaemic stroke hospitalisation increases the risk of stroke recurrence	14
Serum bilirubin and ischaemic stroke: a review of literature	14
Cardiac natriuretic peptides for diagnosis of covert atrial fibrillation after acute ischaemic stroke: a meta-analysis of diagnostic accuracy studies	14
Impact of COVID-2019 on stroke services in China: survey from the Chinese Stroke Association	14
Would integrated Western and traditional Chinese medicine have more benefits for stroke rehabilitation? A systematic review and meta-analysis	14
Associations between haemodynamics and wall enhancement of intracranial aneurysm	14
Management characteristics and prognosis after stroke in China: findings from a large nationwide stroke registry	14
Contemporary antiplatelet therapy for secondary stroke prevention: a narrative review of current literature and guidelines	14
Donning and doffing of personal protective equipment protocol and key points of nursing care for patients with COVID-19 in ICU	14
Cilostazol for secondary stroke prevention: systematic review and meta-analysis	13
Poststroke motor, cognitive and speech rehabilitation with brain–computer interface: a perspective review	13
Advances in mechanical thrombectomy for acute ischaemic stroke from large vessel occlusions	13
Residual recurrence risk of ischaemic cerebrovascular events: concept, classification and implications	13
Gene panel for Mendelian strokes	12
Endovascular treatment for basilar artery occlusion: a meta-analysis	12
Providing uninterrupted care during COVID-19 pandemic: experience from Beijing Tiantan Hospital	12
Stroke in COVID-19: a single-centre initial experience in a hotspot of the pandemic	12
Long-term outcomes of brainstem arteriovenous malformations after different management modalities: a single-centre experience	12
Whole genome sequencing of 10K patients with acute ischaemic stroke or transient ischaemic attack: design, methods and baseline patient characteristics	11
Cellular and molecular imaging for stem cell tracking in neurological diseases	11
Endovascular treatment in anterior circulation stroke beyond 6.5 hours after onset or time last seen well: results from the MR CLEAN Registry	11
Tranexamic acid for intracerebral haemorrhage within 2 hours of onset: protocol of a phase II randomised placebo-controlled double-blind multicentre trial	11
H2S promotes developmental brain angiogenesis via the NOS/NO pathway in zebrafish	11
Clinician’s perspectives in using head impulse-nystagmus-test of skew (HINTS) for acute vestibular syndrome: UK experience	11
LDL-C levels, lipid-lowering treatment and recurrent stroke in minor ischaemic stroke or TIA	10
Deeper cerebral hypoperfusion leads to spatial cognitive impairment in mice	10
Cumulative burden of lipid profiles predict future incidence of ischaemic stroke and residual risk	10

Risk of ischaemic stroke in patients with transient global amnesia: a propensity-matched cohort study	10
Big data and artificial intelligence discover novel drugs targeting proteins without 3D structure and overcome the undruggable targets	10
Emergency medical services use and its association with acute ischaemic stroke evaluation and treatment in Singapore	10
Who may benefit from lower dosages of intravenous tissue plasminogen activator? Results from a cluster data analysis	10
Endovascular treatment with or without intravenous alteplase for acute ischaemic stroke due to basilar artery occlusion	10
Vascular protection and regenerative effects of intranasal DL-3-N-butylphthalide treatment after ischaemic stroke in mice	10
Approaches to global stroke care during the COVID-19 pandemic	10
Safety and efficacy of oral antiplatelet for patients who had acute ischaemic stroke undergoing endovascular therapy	9
China Stroke Statistics 2019: a wealth of opportunities for stroke prevention	9
Advances in endovascular aneurysm management: flow modulation techniques with braided mesh devices	9
Staged angioplasty versus regular carotid artery stenting in patients with carotid artery stenosis at high risk of hyperperfusion: a randomised clinical trial	9
Effects and safety of aspirin use in patients after cerebrovascular bypass procedures	9
Pertussis toxin–induced inflammatory response exacerbates intracerebral haemorrhage and ischaemic stroke in mice	9
Development and validation of a novel nomogram to predict aneurysm rupture in patients with multiple intracranial aneurysms: a multicentre retrospective study	9
Impairment of cognition and sleep after acute ischaemic stroke or transient ischaemic attack in Chinese patients: design, rationale and baseline patient characteristics of a nationwide multicentre pro	9
Remote ischaemic conditioning for stroke: unanswered questions and future directions	9
Comparison of outcome of patients with acute minor ischaemic stroke treated with intravenous t-PA, DAPT or aspirin	9
Predictors of dysphagia screening and pneumonia among patients with acute ischaemic stroke in China: findings from the Chinese Stroke Center Alliance (CSCA)	8
Impaired glymphatic system as evidenced by low diffusivity along perivascular spaces is associated with cerebral small vessel disease: a population-based study	8
Prediction of large vessel occlusion for ischaemic stroke by using the machine learning model random forests	8
Circle of Willis variants are not associated with thrombectomy outcomes	8
Endarterectomy for symptomatic non-stenotic carotids: a systematic review and descriptive analysis	8
Deep learning for automatically predicting early haematoma expansion in Chinese patients	8
Stroke care during the COVID-19 outbreak in Spain: the experience of Spanish stroke units	8
Functional status at 30 and 90 days after mild ischaemic stroke	8
Lower risk of subarachnoid haemorrhage in diabetes: a nationwide population-based cohort study	8
Multiple hypointense vessels on susceptibility-weighted imaging predict early neurological deterioration in acute ischaemic stroke patients with severe intracranial large artery stenosis or occlusion	8
Association between cumulative exposure to different lipid parameters and risk of newly developed carotid plaque	8
Thrombolysis with alteplase 3–4.5 hours after acute ischaemic stroke: the first multicentre, phase III trial in China	7
To bridge or not to bridge: summary of the new evidence in endovascular stroke treatment	7
Long-term modification of gut microbiota by broad-spectrum antibiotics improves stroke outcome in rats	7
Association between coexisting intracranial artery and extracranial carotid artery atherosclerotic diseases and ipsilateral cerebral infarction: a Chinese Atherosclerosis Risk Evaluation (CARE-II) stu	7
Trends and predictors of myocardial infarction or vascular death after ischaemic stroke or TIA in China, 2007–2018: insights from China National Stroke Registries	7
Risk factors for carotid plaque progression after optimising the risk factor treatment: substudy results of the Atherosclerotic Plaque Characteristics Associated with a Progression Rate of the Plaque	7
Safety of endovascular therapy for symptomatic intracranial artery stenosis: a national prospective registry	7
CCL17 exerts neuroprotection through activation of CCR4/mTORC2 axis in microglia after subarachnoid haemorrhage in rats	7
Statin treatment for unruptured intracranial aneurysms study: a study protocol for a double-blind, placebo-controlled trial	7
Clinical imaging factors of excellent outcome after thrombolysis in large-vessel stroke: a THRACE subgroup analysis	7
Headache in cerebrovascular diseases	7
Lesion-symptom mapping with NIHSS sub-scores in ischemic stroke patients	7
Efficacy and safety of bridging thrombolysis initiated before transfer in a drip-and-ship stroke service	7
Circulating immune cell landscape in patients who had mild ischaemic stroke	7
Effect of sex differences on prognosis of intravenous thrombolysis: data from the Thrombolysis Implementation and Monitor of Acute Ischemic Stroke in China (TIMS-China)	7
Differences in atheroma between Caucasian and Asian subjects with anterior stroke: A vessel wall MRI study	7
Endovascular therapy in acute anterior circulation large vessel occlusive patients with a large infarct core (ANGEL-ASPECT): protocol of a multicentre randomised trial	6
Secondary prevention medication persistence and prognosis of acute ischaemic stroke or transient ischaemic attack	6
Tenecteplase Reperfusion therapy in Acute ischaemic Cerebrovascular Events-II (TRACE II): rationale and design	6
White matter hyperintensity progression is associated with incident probable dementia or mild cognitive impairment	6
Incidence, prevalence and risk of stroke in patients with Takayasu arteritis: a nationwide population-based study in South Korea	6
Analytical validation of GMEX rapid point-of-care CYP2C19 genotyping system for the CHANCE-2 trial	6
Mobile stroke care expedites intravenous thrombolysis and endovascular thrombectomy	6
Concurrent intracranial and extracranial artery stenosis and the prognosis of transient ischaemic symptoms or imaging-negative ischaemic stroke	6
Effect of thrombectomy on oedema progression and clinical outcome in patients with a poor collateral profile	6
Aetiology of extracranial carotid free-floating thrombus in a prospective multicentre cohort	6
Ambulatory blood pressure profile and stroke recurrence	6
Different contribution of SBP and DBP variability to vascular events in patients with stroke	6
Comparison of the Pipeline embolisation device alone or combined with coiling for treatment of different sizes of intracranial aneurysms	6
Hyperdense artery sign, symptomatic infarct swelling and effect of alteplase in acute ischaemic stroke	6
Smoking influences outcome in patients who had thrombolysed ischaemic stroke: the ENCHANTED study	6
Stem cell treatment improves post stroke neurological outcomes: a comparative study in male and female rats	6
Role of endovascular embolisation for curative treatment of intracranial non-Galenic pial arteriovenous fistula	6
Loss of Wip1 aggravates brain injury after ischaemia/reperfusion by overactivating microglia	6
Associations of blood biomarkers with glomerular filtration rate in patients with TIA and stroke: population-based study	6
Is more evidence needed for thrombectomy in basilar artery occlusion? The BASICS and BEST meta-analytical approaches	6
CO2 combining power and outcomes in patients with acute ischaemic stroke or transient ischaemic attack	6
Thrombolysis of stroke mimics via telestroke	6
Is tenecteplase ready to replace alteplase to treat acute ischaemic stroke? The knowns and unknowns	6
Prominent juxtacortical white matter lesion hallmarksNOTCH3-related intracerebral haemorrhage	5
Neurological outcomes of untreated brainstem cavernous malformations in a prospective observational cohort and literature review	5
Dl-3-n-butylphthalide attenuates brain injury caused by cortical infarction accompanied by cranial venous drainage disturbance	5
Carotid artery endarterectomy in patients with symptomatic non-stenotic carotid artery disease	5
MALAT1 promotes platelet activity and thrombus formation through PI3k/Akt/GSK-3β signalling pathway	5
Risk stratification in symptomatic intracranial atherosclerotic disease with conventional vascular risk factors and cerebral haemodynamics	5
In-hospital complications affect short-term and long-term mortality in ICH: a prospective cohort study	5
Long-term functional outcomes improved with deep brain stimulation in patients with disorders of consciousness	5
Enhanced liver X receptor signalling reduces brain injury and promotes tissue regeneration following experimental intracerebral haemorrhage: roles of microglia/macrophages	5
Haemostatic therapy in spontaneous intracerebral haemorrhage patients with high-risk of haematoma expansion by CT marker: a systematic review and meta-analysis of randomised trials	5
Endovascular treatment for acute ischaemic stroke due to medium vessel occlusion: data from ANGEL-ACT registry	4
Body mass index and clinical outcomes in patients with intracerebral haemorrhage: results from the China Stroke Center Alliance	4
Incidence and outcomes of intracerebral haemorrhage with mechanical compression hydrocephalus	4

Comparative effectiveness of combined antiplatelet treatments in acute minor ischaemic stroke	4
Association of fluid-attenuated inversion recovery vascular hyperintensity with ischaemic events in internal carotid artery or middle cerebral artery occlusion	4
Childhood strokes in China describing clinical characteristics, risk factors and performance indicators: a case-series study	4
Somatic mutation contributing to clonal haematopoiesis is a risk factor of recurrent stroke in first-ever acute ischaemic stroke: a prospective cohort study	4
Temporal trends and rural–urban disparities in cerebrovascular risk factors, in-hospital management and outcomes in ischaemic strokes in China from 2005 to 2015: a nationwide serial cross-sectional su	4
Intra-arterial thrombolytics during endovascular thrombectomy for acute ischaemic stroke in the MR CLEAN Registry	4
Cerebral haemodynamics in symptomatic intracranial atherosclerotic disease: a narrative review of the assessment methods and clinical implications	4
Association between fluid-attenuated inversion recovery vascular hyperintensity and outcome varies with different lesion patterns in patients with intravenous thrombolysis	4
Off-hour effect is not significant in endovascular treatment for anterior circulation large vessel occlusion in a multicentre registry	4
Differential associations of lipoprotein(a) level with cerebral large artery and small vessel diseases	4
NOTCH2NLCexpanded GGC repeats in patients with cerebral small vessel disease	4
Implementation of regional Acute Stroke Care Map increases thrombolysis rates for acute ischaemic stroke in Chinese urban area in only 3 months	4
Mechanical thrombectomy with combined stent retriever and contact aspiration versus stent retriever alone for acute large vessel occlusion: data from ANGEL-ACT registry	4